Allianz Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Allianz Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,096	Closed	-$33K	–	2519
2020 Q1	$33K	Sell	2,096 -580	-22%	-$12.3K	﹤0.01%	2431
2019 Q4	$57K	Buy	+2,676	New	+$55.1K	﹤0.01%	2734
2019 Q2	–	Sell	-47,927	Closed	-$1.23M	–	2755
2019 Q1	$1.23M	Sell	47,927 -251	-0.5%	-$5.74K	﹤0.01%	2025
2018 Q4	$1.11M	Sell	48,178 -1,717	-3%	-$48.5K	﹤0.01%	1988
2018 Q3	$1.6M	Buy	49,895 +4,293	+9%	+$129K	﹤0.01%	2036
2018 Q2	$1.29M	Sell	45,602 -258	-0.6%	-$9.18K	﹤0.01%	2131
2018 Q1	$1.62M	Buy	+45,860	New	+$1.84M	﹤0.01%	2021
2015 Q2	–	Sell	-1,900	Closed	-$68K	–	2484
2015 Q1	$68K	Buy	+1,900	New	+$52.1K	﹤0.01%	2223
2014 Q4	–	Sell	-3,500	Closed	-$68K	–	2390
2014 Q3	$68K	Hold	3,500	–	–	﹤0.01%	2275
2014 Q2	$127K	Hold	3,500	–	–	﹤0.01%	1851
2014 Q1	$136K	Buy	+3,500	New	+$125K	﹤0.01%	1819
2013 Q4	–	Sell	-2,700	Closed	-$97K	–	1898
2013 Q3	$97K	Buy	+2,700	New	+$98.5K	﹤0.01%	1722

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's RIGL Position: Q2 2020 in Review

Allianz Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q2 2020, closing a stake of 2,096 shares — an estimated $33K sold.

Allianz Asset Management first reported a position in RIGL in Q3 2013 and held it in 12 quarters. The position peaked at $1.62M in Q1 2018. 135 funds tracked by Wall St. Rank hold RIGL as of Q2 2020.

Allianz Asset Management reported no remaining Rigel Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Allianz Asset Management sold 2,096 Rigel Pharmaceuticals shares in Q2 2020, an estimated $33K.
Allianz Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 12 quarters.
Allianz Asset Management's Rigel Pharmaceuticals position peaked at $1.62M in Q1 2018.
135 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.